Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3;23(1):105.
doi: 10.1186/s12906-023-03937-6.

Toxic effects of 70% ethanol extract of Moringa stenopetala leaf (Baker f.) Cufod. (Moringaceae) on fetus and placenta of pregnant Wistar rats

Affiliations

Toxic effects of 70% ethanol extract of Moringa stenopetala leaf (Baker f.) Cufod. (Moringaceae) on fetus and placenta of pregnant Wistar rats

Hussen Abdu et al. BMC Complement Med Ther. .

Abstract

Background: Moringa stenopetala leaves (Baker f.) Cufod. (Moringaceae) are used as a staple food and traditional medicine for treating various diseases like malaria, hypertension, stomach pain, diabetes, elevated cholesterol, and removing the retained placenta. Its prenatal toxicity study is minimal. Thus, this study aimed to assess the toxic effects of a 70% ethanol extract of Moringa stenopetala leaf on the fetuses and placentas of pregnant Wistar rats.

Method: Fresh leaves of Moringa stenopetala were collected, dried at room temperature, ground to powder, and extracted using 70% ethanol. For this study, five groups of animals, each containing ten pregnant rats, were used. Groups I-III were experimental groups and treated with 250, 500, and 1000 mg/kg body weight of Moringa stenopetala leaf extract, respectively. Groups IV and V were pair-fed and ad libitum control groups. The extract was given during gestation days 6 to 12. The fetuses were recovered at day 20 of gestation and examined for the presence of developmental delays, gross external malformations, skeletal and visceral defects. Gross and histopathological changes in the placenta were also evaluated.

Results: Compared to the pair-fed control group, maternal daily food intake and weight gain were reduced in the 1000 mg/kg-treated group during the treatment and post-treatment periods. A significantly higher number of fetal resorptions was also seen in the 1000 mg/kg treatment group. The crown-rump length and fetal and placental weights were all significantly reduced in pregnant rats given 1000 mg/kg. However, there were no visible malformations in the visceral organs as well as external genitalia in all the treatment and control groups. About 40.7% of the fetuses in the 1000 mg/kg treated rats had no proximal hindlimb phalanges. In addition, light microscopic investigations of the placenta in the high-dose treated rats revealed structural changes in the decidual basalis, trophoblastic zone, and labyrinthine zones.

Conclusion: In conclusion, consumption of M. stenopetala leaves at a higher dose may have toxic effects on the development of rat fetuses. At a higher dose, the plant extract increased the number of fetal resorptions, reduced the number of fetuses, decreased the fetal and placental weights, and alter the placental histopathology. Thus, it is recommended to limit the excess feeding of M. stenopetala leaves during gestation.

Keywords: Developmental retardation; Fetus; Moringa stenopetala; Placenta; Rat; Toxic effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Mean maternal daily food intake (g/day) of pregnant rats treated with 70% ethanol leaf extract of M. stenopetala
Fig. 2
Fig. 2
Showing implantation sites (I) and fetal resorption (*) on the gravid uterus of rat treated with 70% ethanol leaf extract of M. stenopetala leaf: a ad libitum control, b 500 mg/kg, c 1000 mg/kg groups
Fig. 3
Fig. 3
Shows live fetus from each group: a 250 mg/kg; b 500 mg/kg; c 1000 mg/kg; d pair-fed control and e ad libitum control groups
Fig. 4
Fig. 4
Bouin’s fixed fetuses for visceral examination (1000 mg/kg). A Un-sectioned fetus showing sites where sections made; B coronal section showing normal palate (p), eye ball (e) and brain ventricle; C coronal section of nasal cavity showing nasal septum (s), nasal conchae (c) and palate (p); D a section made through the neck showing normal 1-esophagus, 2-trachea, and 3-thyroid; E heart showing superior vena cava (SV), aorta (A), coronary artery (ca) F a section through the chest showing normal interventricular septum (s) and lungs (l) G intact diaphragm, H a section made through the abdomen showing normal visceral organs including the liver (l) kidney (k), stomach (s); I section showing pelvic visceral organs (doted)
Fig. 5
Fig. 5
Alizarin red stained 20 days old rat fetuses showing different ossification centers. a: clavicle; b: hyoid; c: sternum; d: vertebrae; e: metatarsals; f: forelimb phalanges; g: supra-occipital and interparietal; h: metacarpals
Fig. 6
Fig. 6
Shows sample of placentae taken from each group; G-I: 250 mg/kg; G-II: 500 mg/kg; G-III: 1000 mg/kg; G-IV: pair-fed control and G-V: ad libitum control groups
Fig. 7
Fig. 7
Photomicrographs of the placenta of rats treated with 1000 mg/kg/day of M. stenopetala leaf extracts showing; a trophoblast proliferation ( formula image ); b hemorrhage in the trophoblastic and labyrinth zones ( formula image ); c capillary dilatation (*); d decidual apoptosis (red arrow), decidual cytolysis (black arrows); e decidual necrosis (head arrow); H&E stain, a & b 100× and c, d & e 40× magnification
Fig. 8
Fig. 8
Photomicrographs of the placenta of pair-fed (a) and ad libitum (b) control groups of rats showing normal structural architecture: decidual basalis (DB); trophoblastic zone (TZ); and labyrinth zone (LZ); H&E stain, 40× magnification

Similar articles

Cited by

References

    1. Atangwho IJ, et al. Extract of Vernonia amygdalina Del.(African bitter leaf) can reverse pancreatic cellular lesion after alloxan damage in the rat. Aust J Basic Appl Sci. 2010;4(5):711–716.
    1. Farnsworth NR. Ethnopharmacology and future drug development: the North American experience. J Ethnopharmacol. 1993;38(2–3):137–143. doi: 10.1016/0378-8741(93)90009-T. - DOI - PubMed
    1. Cox PA. The ethnobotanical approach to drug discovery: strengths and limitations. Ciba Found Symp. 1994;185:25–36. discussion 36-41. PMID: 7736859. - PubMed
    1. Van der Nat J, et al. Immunomodulatory activity of an aqueous extract of Azadirachta indica stem bark. J Ethnopharmacol. 1987;19(2):125–131. doi: 10.1016/0378-8741(87)90036-5. - DOI - PubMed
    1. Lapa-Guimaraes J, Pickova J. New solvent systems for thin-layer chromatographic determination of nine biogenic amines in fish and squid. J Chromatogr A. 2004;1045(1–2):223–232. doi: 10.1016/j.chroma.2004.06.014. - DOI - PubMed

LinkOut - more resources